Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Molecular Targeted Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06376773
What this trial is testing

Neoadjuvant Treatment Based on Gastric Cancer Molecular Subtyping.

Who this might be right for
Advanced Gastric CancerNeoadjuvant TherapyMulti-omics Analysis
Fujian Medical University 234
Testing effectiveness (Phase 2)Ended earlyNCT00671645
What this trial is testing

Preoperative Combined RadioChemo-Molecular Target Therapy With Capecitabine, Bevacizumab, and Radiotherapy

Who this might be right for
Rectal Cancer
Austrian Breast & Colorectal Cancer Study Group 8
Early research (Phase 1)Study completedNCT04023669
What this trial is testing

Evaluation of LY2606368 Therapy in Combination With Cyclophosphamide or Gemcitabine for Children and Adolescents With Refractory or Recurrent Group 3/Group 4 or SHH Medulloblastoma Brain Tumors

Who this might be right for
Brain TumorBrain Tumor, RecurrentBrain Tumor, Refractory+10 more
St. Jude Children's Research Hospital 21
Not applicableLooking for participantsNCT06218901
What this trial is testing

Association of Psychological Distress in Patients With Lung Cancer

Who this might be right for
Lung NeoplasmsPsychological DistressPrognosis Factors+3 more
Shanghai Chest Hospital 500
Very early researchNot Yet RecruitingNCT07280793
What this trial is testing

CAR-T Cell Efficacy With Molecular Imaging in Multiple Myeloma

Who this might be right for
Non-invasive CAR-T Cell MonitoringBCMA-targeted PET ImagingCAR-T Cell Biodistribution and Persistence+1 more
Xuzhou Medical University 10
Very early researchStudy completedNCT04586452
What this trial is testing

NIH CCR2 AAA Study

Who this might be right for
Abdominal Aortic Aneurysm (AAA)No Abdominal Aortic Aneurysm (Non-AAA)
Washington University School of Medicine 50
Testing effectiveness (Phase 2)Study completedNCT00514046
What this trial is testing

Vandetanib to Treat Children and Adolescents With Medullary Thyroid Cancer

Who this might be right for
Medullary Thyroid CarcinomaMultiple Endocrine Neoplasia Type 2AMultiple Endocrine Neoplasia Type 2B
National Cancer Institute (NCI) 17
Testing effectiveness (Phase 2)Study completedNCT01726582
What this trial is testing

Pancreas Cancer: Molecular Profiling as a Guide to Therapy Before and After Surgery ("Personalized Medicine")

Who this might be right for
Pancreatic Adenocarcinoma
Medical College of Wisconsin 229
Early research (Phase 1)UnknownNCT02800369
What this trial is testing

Study of Molecular-targeted Therapy Using Zinc Finger Nuclease in Cervical Precancerous Lesions

Who this might be right for
Human Papillomavirus-Related Malignant Neoplasm
Huazhong University of Science and Technology 20
Not applicableLooking for participantsNCT06228599
What this trial is testing

Molecular Profile-related Individualized Targeted Therapy in Resected Pancreatic Cancer With High-Risk of Cancer Recurrence

Who this might be right for
Pancreas Cancer
Medical College of Wisconsin 40
Not applicableUnknownNCT02523495
What this trial is testing

The Clinical Outcome and the Exploration of Related Biomarkers of Target Therapy in Metastasis Colorectal Cancer

Who this might be right for
Neoplasms, Therapy-Associated
Huazhong University of Science and Technology 120
Early research (Phase 1)Study completedNCT02766699
What this trial is testing

Evaluate the Safety, Tolerability and Immunogenicity of EGFR(V)-EDV-Dox in Subjects With Recurrent GBM

Who this might be right for
GlioblastomaAstrocytoma, Grade IV
Engeneic Pty Limited 9
Testing effectiveness (Phase 2)Study completedNCT02596828
What this trial is testing

Prospective Pilot Trial to Assess a Multimodal Molecular Targeted Therapy in Children, Adolescent and Young Adults With Relapsed or Refractory High-grade Pineoblastoma

Who this might be right for
Pineoblastoma
University of Regensburg 4
Testing effectiveness (Phase 2)UnknownNCT04160416
What this trial is testing

MXELOXIRI Combined With Molecular Targeted Drug in mCRC

Who this might be right for
Unresectable Metastatic Colorectal Cancer
First Affiliated Hospital of Zhejiang University 48
Early research (Phase 1)Study completedNCT01473095
What this trial is testing

Phase 1 Dose Escalation Study of ARQ 092 in Adult Subjects With Advanced Solid Tumors and Recurrent Malignant Lymphoma

Who this might be right for
Solid TumorMalignant LymphomaTumor
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 120
Large-scale testing (Phase 3)Looking for participantsNCT05770544
What this trial is testing

DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusion-Positive Cancers.

Who this might be right for
Haematological MalignancyMalignancyMalignant Neoplasm+8 more
Cancer Research UK 30
Post-approval studies (Phase 4)UnknownNCT05187208
What this trial is testing

PARP Inhibitor Oral Maintenance in Low-Risk Ovarian Cancer

Who this might be right for
Epithelial Ovarian CancerOvarian CancerOvarian Cancer Stage III+1 more
Seoul National University Hospital 102
Testing effectiveness (Phase 2)UnknownNCT03772132
What this trial is testing

Chemothetapy FORFIRINOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma

Who this might be right for
Cholangiocarcinoma of the Extrahepatic Bile DuctGallbladder Cancer
Shanghai Jiao Tong University School of Medicine 100
Large-scale testing (Phase 3)Looking for participantsNCT07440290
What this trial is testing

DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.

Who this might be right for
Haematological MalignancyMalignant NeoplasmLymphoproliferative Disorders+17 more
Cancer Research UK 30
Early research (Phase 1)Study completedNCT00055380
What this trial is testing

Chemical and Genetic Effects of the Experimental Anti-Cancer Drugs in Cheek Cells in Cancer Patients

Who this might be right for
Cancer
National Institute of Dental and Craniofacial Research (NIDCR) 120
Next Page